Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
about
Quantitative phenotypic and pathway profiling guides rational drug combination strategiesReverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical UseReverse phase protein microarrays advance to use in clinical trialsElevated pressure improves the extraction and identification of proteins recovered from formalin-fixed, paraffin-embedded tissue surrogatesApplication of machine learning to proteomics data: classification and biomarker identification in postgenomics biology.Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomicsRealizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.State-of-the-art MS technology applications in lung disease.Advancing cancer drug discovery towards more agile development of targeted combination therapies.Diversity of matriptase expression level and function in breast cancer.Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling.Progress in mining the human proteome for disease applicationsRecent progress in protein profiling of clinical tissues for next-generation molecular diagnostics.Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA)Overview: the maturing of proteomics in cardiovascular research.PKC signaling prevents irradiation-induced apoptosis of primary human fibroblastsMultiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arraysAdvances in the proteomic discovery of novel therapeutic targets in cancer.PKCα and HMGB1 antagonistically control hydrogen peroxide-induced poly-ADP-ribose formation.Systematic antibody and antigen-based proteomic profiling with microarrays.Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.Evanescent wave fluorescence biosensors: Advances of the last decadeAntibody-Based Proteomics.TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3pReverse Phase Protein Arrays and Drug Discovery.Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.Preservation of Specific Protein Signaling States Using Heat Based Stabilizor System.Monitoring protein expression in whole-cell extracts by targeted label- and standard-free LC-MS/MS.Antibody array-based immunosensor for detecting cardiovascular disease risk markers.
P2860
Q27021150-CBCF92B7-C1E6-47E5-91A3-850C7721CF05Q28083256-93D44171-4ABC-4FA0-9E29-70DFD85E5937Q28384553-064C73AA-2924-44FC-82C8-089C628E7D75Q28744384-20804A70-AA2D-45B8-86F5-2122C37E0115Q30676067-D3A60583-16D1-4171-BB1A-9A7EE12621C0Q33688456-69C48764-8B5E-4F85-8732-6AFC7DD6AC91Q33850616-AB0439A1-8255-4DFB-8B4F-E2CA53F3E179Q34089332-1E993076-2FE8-474C-A9B2-56A1209D3267Q34100574-316DD8C9-89B0-414C-AEB3-06CD9E610FF5Q34238503-A9E7E894-62CA-44FA-9EC6-F5048F6B29B5Q34983997-2224622B-8FFB-4A64-8423-F84B8A69C1F3Q35056154-1D7D78A3-6856-4886-89B1-6EE9759655D5Q35714211-1228A51E-01F0-4E0D-8B7C-AB4B9BA1FB1DQ36134032-C35AE3B9-B0B2-43EC-BA9D-484B127AADD7Q36406428-8CCD8A50-0F63-4034-B50A-2E5747EA6EE6Q37073602-06438895-3C38-41C5-98E3-CE7C9E7444BBQ37160952-B0444D82-0E94-494E-AF1B-58760B671FDBQ37260569-C4508633-46D9-470C-AAB4-6233D343674FQ37264322-6C58B5DA-7A84-4AAE-89BD-773B78BE6B6EQ37853185-32B38E58-0152-4CC9-A464-F5D374A2DF02Q38148583-5DB07C2C-385C-4245-9899-CD98CA449817Q38558701-4B6B3A58-4845-4626-B4A5-3C15C3DF138EQ38968223-084F6A6F-5E63-4496-843C-6FEEB8F65D76Q42378963-82D5820C-99F1-4F26-89A6-E58625AB4B11Q47951500-668A5576-3AE5-4942-958C-0FBDC10D1598Q48570977-38B3A0DD-6FD3-4919-A71F-0315F53E684FQ51142812-5E3152CB-7F99-440E-92E1-61B2C73E31F6Q52894941-406786DC-286D-4051-8B25-AEECB96B05EBQ53779971-38FC6675-FA98-4B01-8924-5C3BE221AC5C
P2860
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
@en
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
@nl
type
label
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
@en
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
@nl
prefLabel
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
@en
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
@nl
P2093
P2860
P1433
P1476
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
@en
P2093
Eric Bertrand
Hans Voshol
Jan van Oostrum
Jens Traenkle
Markus Ehrat
P2860
P304
P356
10.1111/J.1742-4658.2009.07395.X
P407
P577
2009-10-26T00:00:00Z